Founded
31 Dec 2021

Address

Zephyr AI Inc
Parkland Hall At Old Parkland
3889 Maple Avenue, Suite 500
Dallas, TX 75219
United States

Open Map

Zephyr AI Inc
1800 Tysons Blvd, Suite 901
Mclean, VA 22102
United States

Open Map

Business classification

VCID: 7713555
    Profile

    Corporate information

    Official name
    Zephyr AI Inc

    Registration country

    Official identities

    US CIK 0001915384

    Investment activity status
    Active investor

    Company type

    Precision medicine startup.

    Overview

    Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease. Through partnerships and proprietary data, Zephyr AI is curating the world’s most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms to generate novel, translatable insights to build tools and products that support patients and providers and fuel ongoing research. At Zephyr AI, our mission-focused team of world-class software engineers and biologists leverage big data and next-generation technology to derive transformational insights and build enduring partnerships that will revolutionize the treatment of cancer and cardiometabolic disease.

    Funding rounds

    Series A USD 111,000,000


    USD 111,000,000 (13 Mar 2024)

    Profile Country Notes
    Eli Lilly & Co Initial investment. Round participant.
    EPIQ Capital Group LLC Multi-family office and investment firm. Initial investment. Round participant.
    Jeffrey Skoll Initial investment. Round participant.
    Revolution Management Co LLC United States Initial investment. Round participant.

    Current and past shareholders